New York State Common Retirement Fund’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.7M | Sell |
404,249
-17,384
| -4% | -$729K | 0.03% | 410 |
|
|
2026
Q1 | $13.6M | Sell |
421,633
-164,609
| -28% | -$6.09M | 0.02% | 572 |
|
|
2025
Q4 | $24.7M | Sell |
586,242
-78,484
| -12% | -$3.16M | 0.03% | 357 |
|
|
2025
Q3 | $22.8M | Sell |
664,726
-12,112
| -2% | -$347K | 0.03% | 414 |
|
|
2025
Q2 | $18.3M | Buy |
676,838
+9,509
| +1% | +$275K | 0.02% | 486 |
|
|
2025
Q1 | $19.8M | Sell |
667,329
-118,642
| -15% | -$4.52M | 0.03% | 420 |
|
|
2024
Q4 | $31.1M | Buy |
785,971
+3,111
| +0.4% | +$118K | 0.04% | 310 |
|
|
2024
Q3 | $26.6M | Sell |
782,860
-105,937
| -12% | -$2.98M | 0.04% | 372 |
|
|
2024
Q2 | $19.3M | Buy |
888,797
+26,214
| +3% | +$551K | 0.03% | 522 |
|
|
2024
Q1 | $19.1M | Buy |
862,583
+25,116
| +3% | +$613K | 0.03% | 544 |
|
|
2023
Q4 | $23M | Sell |
837,467
-69,814
| -8% | -$1.69M | 0.03% | 467 |
|
|
2023
Q3 | $20.3M | Buy |
907,281
+71,418
| +9% | +$1.84M | 0.03% | 495 |
|
|
2023
Q2 | $21.3M | Sell |
835,863
-50,045
| -6% | -$1.21M | 0.03% | 532 |
|
|
2023
Q1 | $19.8M | Sell |
885,908
-16,854
| -2% | -$407K | 0.03% | 573 |
|
|
2022
Q4 | $21.4M | Buy |
902,762
+31,319
| +4% | +$728K | 0.03% | 535 |
|
|
2022
Q3 | $14.5M | Buy |
871,443
+11,758
| +1% | +$265K | 0.02% | 670 |
|
|
2022
Q2 | $17.1M | Sell |
859,685
-17,484
| -2% | -$353K | 0.02% | 630 |
|
|
2022
Q1 | $24.2M | Buy |
877,169
+9
| +0% | +$257 | 0.03% | 542 |
|
|
2021
Q4 | $36.1M | Sell |
877,160
-184,769
| -17% | -$8.16M | 0.04% | 426 |
|
|
2021
Q3 | $49.3M | Buy |
1,061,929
+43,749
| +4% | +$1.91M | 0.05% | 328 |
|
|
2021
Q2 | $40.7M | Buy |
1,018,180
+3,427
| +0.3% | +$147K | 0.04% | 381 |
|
|
2021
Q1 | $54.5M | Buy |
1,014,753
+122,665
| +14% | +$7.07M | 0.06% | 279 |
|
|
2020
Q4 | $43.7M | Buy |
892,088
+6,429
| +0.7% | +$298K | 0.05% | 358 |
|
|
2020
Q3 | $28.8M | Buy |
885,659
+40,970
| +5% | +$1.3M | 0.04% | 454 |
|
|
2020
Q2 | $21.9M | Buy |
844,689
+78,219
| +10% | +$1.95M | 0.03% | 545 |
|
|
2020
Q1 | $18.6M | Buy |
766,470
+201,635
| +36% | +$5.08M | 0.03% | 547 |
|
|
2019
Q4 | $15.8M | Buy |
564,835
+279,877
| +98% | +$7.24M | 0.02% | 762 |
|
|
2019
Q3 | $6.84M | Buy |
284,958
+62,049
| +28% | +$1.65M | 0.01% | 1099 |
|
|
2019
Q2 | $6.36M | Buy |
222,909
+197,709
| +785% | +$4.94M | 0.01% | 1171 |
|
|
2019
Q1 | $631K | Hold |
25,200
| – | – | ﹤0.01% | 2199 |
|
|
2018
Q4 | $317K | Hold |
25,200
| – | – | ﹤0.01% | 2494 |
|
|
2018
Q3 | $241K | Hold |
25,200
| – | – | ﹤0.01% | 2747 |
|
|
2018
Q2 | $235K | Hold |
25,200
| – | – | ﹤0.01% | 2804 |
|
|
2018
Q1 | $140K | Hold |
25,200
| – | – | ﹤0.01% | 2868 |
|
|
2017
Q4 | $165K | Hold |
25,200
| – | – | ﹤0.01% | 2841 |
|
|
2017
Q3 | $221K | Hold |
25,200
| – | – | ﹤0.01% | 2724 |
|
|
2017
Q2 | $210K | Buy |
25,200
+12,899
| +105% | +$105K | ﹤0.01% | 2820 |
|
|
2017
Q1 | $113K | Buy |
12,301
+1
| +0% | +$8 | ﹤0.01% | 2947 |
|
|
2016
Q4 | $95K | Hold |
12,300
| – | – | ﹤0.01% | 2980 |
|
|
2016
Q3 | $94K | Hold |
12,300
| – | – | ﹤0.01% | 2999 |
|
|
2016
Q2 | $62K | Hold |
12,300
| – | – | ﹤0.01% | 3069 |
|
|
2016
Q1 | $66K | Hold |
12,300
| – | – | ﹤0.01% | 3012 |
|
|
2015
Q4 | $89K | Hold |
12,300
| – | – | ﹤0.01% | 3038 |
|
|
2015
Q3 | $58K | Buy |
12,300
+900
| +8% | +$8.57K | ﹤0.01% | 3103 |
|
|
2015
Q2 | $127K | Buy |
+11,400
| New | +$112K | ﹤0.01% | 3057 |
|
Other funds holding VCYT
AIM
AAMU
ETC
AAP
PA
IEFM
BCM
New York State Common Retirement Fund's VCYT Position: Q2 2026 in Review
New York State Common Retirement Fund reduced its Veracyte (VCYT) stake by 4.1% in Q2 2026, selling an estimated $729K and leaving 404,249 shares worth $23.7M. The position accounts for 0.03% of the portfolio, ranked #410.
New York State Common Retirement Fund first reported a position in VCYT in Q2 2015 and has held it in 45 quarters since. The position peaked at $54.5M in Q1 2021. 92 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- New York State Common Retirement Fund held 404,249 shares of Veracyte worth $23.7M as of Q2 2026.
- New York State Common Retirement Fund sold 17,384 Veracyte shares in Q2 2026, an estimated $729K.
- Veracyte made up 0.03% of New York State Common Retirement Fund's portfolio in Q2 2026, its #410 holding.
- New York State Common Retirement Fund first reported a position in Veracyte in Q2 2015 and has held it in 45 quarters since.
- New York State Common Retirement Fund's Veracyte position peaked at $54.5M in Q1 2021.
- 92 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.